Physician profile
Dannie Chang
NPI 1861830077
$1,047.20
in general payments reported to CMS, 2019-2025
20 companies · $397 in 2025
The $397 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.20 · 2020: $33.95 · 2021: $77.04 · 2022: $149 · 2023: $115 · 2024: $207 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $217.62 | 2023-2025 | Ebglyss, Taltz, Zepbound |
| Abbvie INC. | $149.79 | 2019-2025 | |
| Pfizer INC. | $86.04 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $74.47 | 2022-2025 | |
| Genzyme Corporation | $59.21 | 2024-2025 | |
| Amgen INC. | $48.43 | 2024-2025 | Otezla |
| Almirall LLC | $45.54 | 2023-2024 | Klisyri |
| Organon LLC | $45.36 | 2025 | |
| Sun Pharmaceutical Industries INC. | $39.48 | 2021 | |
| Galderma Laboratories, L.P. | $39.02 | 2021-2023 | |
| Dermira, INC. | $35.81 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.33 | 2023 | Sotyktu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.27 | 2025 | Spevigo |
| Leo Pharma INC. | $28.25 | 2022 | |
| Verrica Pharmaceuticals INC. | $23.74 | 2025 | Ycanth |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $20.37 | 2023 | Tremfya |
| Incyte Corporation | $19.72 | 2024 | Opzelura |
| Teva Pharmaceuticals USA, INC. | $18.80 | 2024 | Simlandi |
| Vyne Pharmaceuticals INC. | $18.43 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dannie Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.